A double-blind, placebo-controlled study to assess the effect of gemfibrozil co-administration on the pharmacokinetics and pharmacodynamics of mitiglinide in healthy volunteers

Trial Profile

A double-blind, placebo-controlled study to assess the effect of gemfibrozil co-administration on the pharmacokinetics and pharmacodynamics of mitiglinide in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Mar 2010

At a glance

  • Drugs Gemfibrozil; Mitiglinide
  • Indications Lipid metabolism disorders; Type 2 diabetes mellitus
  • Focus Pharmacokinetics
  • Sponsors Elixir Pharmaceuticals
  • Most Recent Events

    • 11 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top